{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:41:39Z","timestamp":1780342899439,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Mazandaran","award":["1366056"],"award-info":[{"award-number":["1366056"]}]},{"name":"Deputy of Research and Technology of Babol University of Medical Sciences","award":["9604112"],"award-info":[{"award-number":["9604112"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.lfs.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T21:10:13Z","timestamp":1530565813000},"page":"471-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Hesperetin reduces myelin damage and ameliorates glial activation in lysolecithin-induced focal demyelination model of rat optic chiasm"],"prefix":"10.1016","volume":"207","author":[{"given":"Saeideh","family":"Baradaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Hajizadeh Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghasemi-Kasman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2018.07.001_bb0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrn2480","article-title":"Remyelination in the CNS: from biology to therapy","volume":"9","author":"Franklin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2018.07.001_bb0010","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/brain\/awr014","article-title":"Enhancing remyelination in disease\u2014can we wrap it up?","volume":"134","author":"Kotter","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2018.07.001_bb0015","first-page":"1","article-title":"Healthcare resources utilisation in primary progressive multiple sclerosis","author":"Piccinni","year":"2018","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.lfs.2018.07.001_bb0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: a complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbadis.2010.09.010","article-title":"Cells of the oligodendroglial lineage, myelination, and remyelination","volume":"1812","author":"Miron","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.lfs.2018.07.001_bb0035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn917","article-title":"Why does remyelination fail in multiple sclerosis?","volume":"3","author":"Franklin","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2018.07.001_bb0040","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.lfs.2018.07.001_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.58.2.169","article-title":"Disease modifying therapies in multiple sclerosis","volume":"58","author":"Goodin","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2018.07.001_bb0050","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ana.10578","article-title":"Efficient central nervous system remyelination requires T cells","volume":"53","author":"Bieber","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.biopha.2018.02.125","article-title":"Querectin improves myelin repair of optic chiasm in lyolecithin-induced focal demyelination model","volume":"101","author":"Naeimi","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.lfs.2018.07.001_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","article-title":"The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy","volume":"251","author":"Gilgun-Sherki","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1039\/b514294f","article-title":"Natural products to drugs: natural product-derived compounds in clinical trials","volume":"25","author":"Butler","year":"2008","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.lfs.2018.07.001_bb0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S002966511000162X","article-title":"Flavonoids as anti-inflammatory agents","volume":"69","author":"Serafini","year":"2010","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.lfs.2018.07.001_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0080","first-page":"964","article-title":"Hesperetin suppresses inflammatory responses in lipopolysaccharide-induced RAW 264.7 cells via the inhibition of NF-\u03baB and activation of Nrf2\/HO-1 pathways","volume":"39","author":"Ren","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.lfs.2018.07.001_bb0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ptr.5256","article-title":"Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models","volume":"29","author":"Parhiz","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.lfs.2018.07.001_bb0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.lfs.2014.12.030","article-title":"Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases","volume":"124","author":"Roohbakhsh","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2018.07.001_bb0095","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s12272-001-2130-1","article-title":"Neuroprotective effects of chronic hesperetin administration in mice","volume":"31","author":"Choi","year":"2008","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.lfs.2018.07.001_bb0100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1021\/jf2040675","article-title":"Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach","volume":"60","author":"Yang","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2018.07.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.2906","article-title":"Hesperidin suppresses adjuvant arthritis in rats by inhibiting synoviocyte activity","volume":"24","author":"Li","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.lfs.2018.07.001_bb0110","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11064-015-1571-8","article-title":"Hesperidin, a citrus flavonoid, has the ameliorative effects against experimental autoimmune encephalomyelitis (EAE) in a C57BL\/J6 mouse model","volume":"40","author":"Ciftci","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2018.07.001_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneuroim.2016.11.009","article-title":"Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis","volume":"302","author":"Haghmorad","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0120","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1021\/jf800105c","article-title":"In vivo pharmacokinetics of hesperidin are affected by treatment with glucosidase-like BglA protein isolated from yeasts","volume":"56","author":"Li","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2018.07.001_bb0125","series-title":"A Flavanone Glycoside. Polyphenols in Human Health and Disease","first-page":"989","article-title":"Chapter 76 - cardiovascular effects of hesperidin","author":"Zanwar","year":"2014"},{"key":"10.1016\/j.lfs.2018.07.001_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.07.029","article-title":"Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin\u2014a mini-review","volume":"113","author":"Roohbakhsh","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2018.07.001_bb0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jmr.2224","article-title":"Hesperidinase encapsulation towards hesperitin production targeting improved bioavailability","volume":"25","author":"Furtado","year":"2012","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.lfs.2018.07.001_bb0140","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.biopha.2017.11.047","article-title":"Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer's disease","volume":"97","author":"kheradmand","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.lfs.2018.07.001_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment","author":"Robinson","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2017.05.015","article-title":"rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination","volume":"105","author":"Mullin","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2018.07.001_bb0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L","article-title":"Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement\/anti-galactocerebroside: a comparative study","volume":"25","author":"Woodruff","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2018.07.001_bb0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12017-011-8143-0","article-title":"Analysis of structural and molecular events associated with adult rat optic chiasm and nerves demyelination and remyelination; possible role for 3rd ventricle proliferating cells","volume":"13","author":"Mozafari","year":"2011","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.lfs.2018.07.001_bb0165","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s11064-011-0510-6","article-title":"Castration attenuates myelin repair following lysolecithin induced demyelination in rat optic chiasm: an evaluation using visual evoked potential, marker genes expression and myelin staining","volume":"36","author":"Sherafat","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.lfs.2018.07.001_bb0170","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.expneurol.2007.05.014","article-title":"CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure","volume":"209","author":"Fitch","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0175","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/NEN.0b013e3181f3a5b1","article-title":"Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis","volume":"69","author":"Howell","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0180","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2018.07.001_bb0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2016.12.037","article-title":"Pregabalin enhances myelin repair and attenuates glial activation in lysolecithin-induced demyelination model of rat optic chiasm","volume":"344","author":"Daneshdoust","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2018.07.001_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/term.2276","article-title":"In vivo conversion of astrocytes to myelinating cells by miR-302\/367 and valproate to enhance myelin repair","volume":"12","author":"Ghasemi-Kasman","year":"2018","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.lfs.2018.07.001_bb0195","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.pnpbp.2017.07.025","article-title":"Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory deficits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy","volume":"79","author":"Hashemian","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2018.07.001_bb0200","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ijbiomac.2017.09.073","article-title":"Piperine-loaded chitosan-STPP nanoparticles reduce neuronal loss and astrocytes activation in chemical kindling model of epilepsy","volume":"107","author":"Anissian","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2018.03.018","article-title":"Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lyolecithin-induced focal demyelination model of rat corpus callosum","volume":"674","author":"Naeimi","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2018.07.001_bb0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/187152711794480429","article-title":"The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease","volume":"10","author":"Divino da Rocha","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.lfs.2018.07.001_bb0215","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2010.07.026","article-title":"Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination","volume":"1351","author":"Mozafari","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2018.07.001_bb0220","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0006-2952(02)01609-X","article-title":"Flavonoids inhibit myelin phagocytosis by macrophages; a structure\u2013activity relationship study","volume":"65","author":"Hendriks","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2018.07.001_bb0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W","article-title":"Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord","volume":"30","author":"Ousman","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2018.07.001_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention","volume":"304","author":"Liu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2018.07.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/938712","article-title":"Leukocyte production of inflammatory mediators is inhibited by the antioxidants phloretin, silymarin, hesperetin, and resveratrol","volume":"2014","author":"Fordham","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.lfs.2018.07.001_bb0240","first-page":"294","article-title":"Antioxidant and anti-inflammatory potential of hesperidin against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced experimental Parkinson's disease in mice","author":"Tamilselvam","year":"2013","journal-title":"Int. J. Nutr. Pharmacol. Neurol. Dis."},{"key":"10.1016\/j.lfs.2018.07.001_bb0245","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2009.01.016","article-title":"The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury","volume":"484","author":"Vafeiadou","year":"2009","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518303783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518303783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T14:34:38Z","timestamp":1536935678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518303783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":49,"alternative-id":["S0024320518303783"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.07.001","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hesperetin reduces myelin damage and ameliorates glial activation in lysolecithin-induced focal demyelination model of rat optic chiasm","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}